The Dual Roles of Natural Cannabidiol in Combating Oxidative Stress and Inflammation: A Potential Intestinal Guardian
| Journal | Redox biology |
| Study Type | Clinical Study |
| Population | Human participants |
This item covers developments relevant to cannabis medicine and clinical practice. Clinicians monitoring evidence in this area should review the source material.
Cannabidiol (CBD), a non-psychoactive and non-addictive phytocannabinoid derived from Cannabis sativa L., has attracted increasing attention for its therapeutic potential in intestinal diseases. Accumulating evidence indicates that CBD exerts prominent antioxidant and anti-inflammatory effects within the gastrointestinal tract. Oxidative stress and redox imbalance are key drivers of epithelial barrier dysfunction, chronic inflammation, and disease progression in disorders such as inflammatory bowel disease (IBD) and colorectal cancer (CRC). This review focuses on the redox-related mechanisms underlying CBD’s intestinal protective actions, highlighting its ability to regulate reactive oxygen species (ROS) production, activate the Nrf2-Keap1 antioxidant pathway, and modulate redox-sensitive inflammatory signaling, including NF-κB and the NLRP3 inflammasome. In parallel, CBD engages the endocannabinoid system (ECS) and related receptors to preserve epithelial barrier integrity, regulate g
“This is a development worth tracking. The clinical implications will become clearer as more evidence accumulates.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
What does this review say about CBD and the intestines?
The review states that accumulating evidence indicates CBD has prominent antioxidant and anti-inflammatory effects within the gastrointestinal tract. It focuses on the redox-related mechanisms that may underlie CBD’s protective actions in the intestine. It was published in the journal Redox Biology.
Why does oxidative stress matter in bowel diseases like IBD?
According to the review, oxidative stress and redox imbalance are key drivers of epithelial barrier dysfunction, chronic inflammation, and disease progression. It names inflammatory bowel disease (IBD) and colorectal cancer (CRC) as examples of such disorders. This link helps explain why the review focuses on redox-related mechanisms of CBD’s protective effects.
How might CBD protect the intestine according to this review?
The review highlights several proposed mechanisms. CBD may regulate production of reactive oxygen species, activate the Nrf2-Keap1 antioxidant pathway, and modulate redox-sensitive inflammatory signaling such as NF-κB and the NLRP3 inflammasome. CBD also engages the endocannabinoid system and related receptors to help preserve the integrity of the epithelial barrier.
Is the CBD discussed in this review psychoactive or addictive?
The review describes cannabidiol, or CBD, as a non-psychoactive and non-addictive phytocannabinoid derived from Cannabis sativa L. It notes that CBD has attracted increasing attention for its therapeutic potential in intestinal diseases, which is the focus of this review.
Get the next evidence review in your inbox
Plain-language summaries of the newest cannabis research, written by a physician. Free to read, and you can unsubscribe at any time.
Join the growing cannabis community. Free. One-click subscribe. Delivered by Substack.
